dalfampridine 10 MG 12HR Extended Release Oral Tablet

RxCUI
897021
RxNorm name
dalfampridine 10 MG 12HR Extended Release Oral Tablet
Display name
dalfampridine 10 MG 12HR Extended Release Oral Tablet
Full name
dalfampridine 10 MG 12HR Extended Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DalfampridineDALFAMPRIDINEAscend Laboratories, LLCe10b2d92-2824-4395-8883-6fd52c784aa42026-07-14Warnings, Adverse reactionsExact identifier
rxcui: 897021
AMPYRADALFAMPRIDINEMerz Pharmaceuticals, LLC550eb76a-e4a6-4fa1-ad65-c0fd8b0ce7832026-01-16Warnings, Adverse reactionsExact identifier
rxcui: 897021
DalfampridineDALFAMPRIDINEAccord Healthcare Inc.354a97e8-35c8-418b-91b2-9e8e066cec652025-10-09Warnings, Adverse reactionsExact identifier
rxcui: 897021
DALFAMPRIDINEDALFAMPRIDINEMicro Labs Limited302c8270-4711-4ca4-bee8-be0738fbe0942025-07-28Warnings, Adverse reactionsExact identifier
rxcui: 897021
DalfampridineDALFAMPRIDINECivicaScript LLCc40dcc84-b839-44aa-94f2-886fb1c3d75c2025-07-16Warnings, Adverse reactionsExact identifier
rxcui: 897021
AMPYRADALFAMPRIDINEMerz Pharmaceuticals, LLC974fb2af-7012-4989-b330-e44a31c9c3e52025-05-05Warnings, Adverse reactionsExact identifier
rxcui: 897021
DALFAMPRIDINEDALFAMPRIDINEBryant Ranch Prepack688eb479-debc-4cfc-a74d-14828c3470492025-02-12Warnings, Adverse reactionsExact identifier
rxcui: 897021
DALFAMPRIDINEDALFAMPRIDINEAurobindo Pharma Limited43996322-7d83-4420-9e61-4ed37f710fee2024-02-15Warnings, Adverse reactionsExact identifier
rxcui: 897021
DalfampridineDALFAMPRIDINEGolden State Medical Supply, Inc.1134ac0f-59c1-a20b-e063-6294a90affcc2024-02-12Warnings, Adverse reactionsExact identifier
rxcui: 897021
DalfampridineDALFAMPRIDINESun Pharmaceutical Industries, Inc.d61e15fa-0334-49a0-ab41-c9a36b726b572023-10-16Warnings, Adverse reactionsExact identifier
rxcui: 897021
DalfampridineDALFAMPRIDINEActavis Pharma, Inc.ed826777-b8c4-4d35-aa64-a4c28452baa82021-12-02Warnings, Adverse reactionsExact identifier
rxcui: 897021

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 12 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b9ad68e2-a515-4dba-915d-401c555a8a26dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]3101These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020230316
688eb479-debc-4cfc-a74d-14828c347049dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]3100These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020250212
550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]322These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA ® (dalfampridine) extended-release tablets, for oral use Initial U.S. Approval: 201020260116
e10b2d92-2824-4395-8883-6fd52c784aa4dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]312These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020230130
302c8270-4711-4ca4-bee8-be0738fbe094dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]39These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020250728
ed826777-b8c4-4d35-aa64-a4c28452baa8dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]39These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020211202
354a97e8-35c8-418b-91b2-9e8e066cec65dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]38These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020251009
d61e15fa-0334-49a0-ab41-c9a36b726b57dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]37These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020231016
43996322-7d83-4420-9e61-4ed37f710feedalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]36These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020240215
c40dcc84-b839-44aa-94f2-886fb1c3d75cdalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]31These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020250716
974fb2af-7012-4989-b330-e44a31c9c3e5dalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]31These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA ® (dalfampridine) extended-release tablets, for oral use Initial U.S. Approval: 201020250505
1134ac0f-59c1-a20b-e063-6294a90affccdalfampridine 10 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR dalfampridine 10 MG Extended Release Oral Tablet [SCD] · dalfampridine 10 MG 12 HR Extended Release Oral Tablet [SY]31DALFAMPRIDINE EXTENDED-RELEASE TABLETS. These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DALFAMPRIDINE EXTENDED-RELEASE TABLETS. DALFAMPRIDINE extended-release tablets, for oral use Initial U.S. Approval: 201020240212